Fundraising FoxCapable
7 known investors
Find your way into Capable
Sign up to see every warm intro you have to Capable
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Capable team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Capable is a vertically integrated, AI-enabled deeptech platform developing peptide and nucleotide therapeutics using automated polymer synthesis, drawing on rare human genetic variants. Its first programs focus on sleep, targeting rare sleep diseases such as narcolepsy and hypersomnia with therapeutics aimed at improving cognitive performance under sleep deprivation.
Investors · 7
How we know: Harpoon Ventures's portfolio page · Not right? Tell us
How we know: scribble.vc · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
How we know: funding news · press coverage · Not right? Tell us
Funding
SEC filings, press & company announcements- Undisclosed amountPre-SeedJun 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Capable do?
- Capable is a vertically integrated, AI-enabled deeptech platform developing peptide and nucleotide therapeutics using automated polymer synthesis, drawing on rare human genetic variants. Its first programs focus on sleep, targeting rare sleep diseases such as narcolepsy and hypersomnia with therapeutics aimed at improving cognitive performance under sleep deprivation.
- Who are Capable's investors?
- Capable's investors include GoAhead Ventures, Harpoon Ventures, HOF Capital, Scribble Ventures, Able Partners, AlleyCorp, M13.